A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2007
10/31/2007	CN101062025A Compound anget for reducing weight, fat, sugar, pressure and for preventing and treating osteoporosis
10/31/2007	CN101062024A Pronin medicinal composition and its preparing method
10/31/2007	CN101062022A Colchicine patch absorbing from skin for treating acute goute arthritis and the preparing method thereof
10/31/2007	CN101062021A Diarrhea treating medical composition
10/31/2007	CN101062020A Tiotropium bromide capsule type dry powder inhalations and the preparing method thereof
10/31/2007	CN101062019A Lappaconitine hydrobromide transparent patch and the preparing method thereof
10/31/2007	CN101062018A Hydrochloride clindamycin palmitate soft capsule and the preparing method thereof
10/31/2007	CN101062017A Hyaluronic acid and preparation process thereof
10/31/2007	CN101062016A Immune micro-liposomal used in the cancer developing, diagnosing and treating and the application thereof
10/31/2007	CN101062015A Urease epitope fusion peptide liposome bacterin for preventing the helicobacter pylori infecting
10/31/2007	CN101062014A Compound hydrochloride doxycycline injection for animals and the preparing method thereof
10/31/2007	CN101062013A Hydrochloride doxycycline injection for animals and the preparing method
10/31/2007	CN101062012A Narcotic analgesics injection liquid
10/31/2007	CN101062011A Calcium dobesilate injection
10/31/2007	CN101062010A 复方琥珀酰明胶注射液 Compound gelofusion Injection
10/31/2007	CN100345842C Dimeric compounds and their use as anti-viral agents
10/31/2007	CN100345833C Modulators of dopamine neurotransmission
10/31/2007	CN100345625C Novel adsorbent
10/31/2007	CN100345596C medicinal aerosol formulation
10/31/2007	CN100345592C Mono and disaccharide derivatives
10/31/2007	CN100345591C Instant freeze-dried fibriogen preparation with anti dry heat treatment
10/31/2007	CN100345590C Lozenge containing liver cell growth promoting agent and interferon
10/31/2007	CN100345582C Medicine for abstaining from drug
10/31/2007	CN100345581C Chinese traditional medicine preparation for curing cervical spondylosis and its preparing method
10/31/2007	CN100345579C Medicine for treating throat pain and hoarse voice
10/31/2007	CN100345577C Preparation method of high allicin garlic powder capsule
10/31/2007	CN100345574C Medicine composition for treating cyclomastopathy
10/31/2007	CN100345571C Medication for treating necrosis of femoral head and preparation method
10/31/2007	CN100345560C Ointment for treating osteoproliferation and protrusion of intervertebral discand preparing method
10/31/2007	CN100345558C Extract product of general flavone of kudzuvine root, preparation method and application
10/31/2007	CN100345557C Medicine for stopping conception and its preparation method
10/31/2007	CN100345555C Pain-relieving
10/31/2007	CN100345554C Compounding medicinal capsule for treating angiitis
10/31/2007	CN100345553C Manufacturing technique of acanthopanax root soft capsule
10/31/2007	CN100345552C Enantiomerically pure beta-d-dioxolane nucleosides with selective anti-hepatitus b virus activity
10/31/2007	CN100345551C Preparation of elaioplast and lipid compound preparation of nucleoside-phosphate compound
10/31/2007	CN100345549C Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
10/31/2007	CN100345547C Method of treating prostatic disease using delayed and/or sustained release vitamin D formulations
10/31/2007	CN100345546C Orally quick disintegrating lornoxicam composition and its prepn process
10/31/2007	CN100345544C Nicergoline oral cavity disintegration tablet and its preparation method
10/31/2007	CN100345542C Tinizadole dental plaster for treating buccal inflammation
10/31/2007	CN100345541C Microcapsules for the delayed, controlled release of perindopril
10/31/2007	CN100345540C Use of ampelopsin in preparing medicine for treating diseases related with aldose reductase
10/31/2007	CN100345536C Pharmaceutical composition comprising 5-methyl-2-2'(chloro-6'-fluoroanilino) phenylacetic acid
10/31/2007	CN100345535C The Controlled release preparation of insulin and its method
10/31/2007	CN100345534C Yinzhi huang capsule, its preparation method and use
10/31/2007	CN100345533C Asiabell polysaccharide tablet of asiabell effective ingredient
10/31/2007	CN100345532C Process for dispersing a fluid in solid particles
10/31/2007	CN100345528C Insert for the treatment of dry eye
10/30/2007	US7288533 Using a dioxaborinane compound
10/30/2007	US7288527 Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester
10/30/2007	US7288318 Cosmetic raw materials having improved properties and processes for preparing the same
10/30/2007	US7288273 Gallotannins and ellagitannins as regulators of cytokine release
10/30/2007	US7288268 Formulation for the treatment of obesity
10/30/2007	US7288267 Bioadhesive nanoparticulate compositions having cationic surface stabilizers
10/30/2007	US7288266 For the high efficiency of in vivo delivery and for the broad tissue distribution
10/30/2007	US7288243 Aerosol drug inhibition of lung metastases
10/30/2007	US7288085 Permanent magnet solenoid pump for an implantable therapeutic substance delivery device
10/30/2007	US7288084 Drug-loaded medical device
10/30/2007	US7287485 Temperature activated systems
10/30/2007	CA2391963C Method for producing a moulded body containing starch
10/30/2007	CA2329232C Stable compositions comprising levosimendan and alginic acid
10/30/2007	CA2328703C Delavirdine tablet formulation
10/30/2007	CA2321741C Method of particle formation
10/30/2007	CA2295755C Syringe and capsule therefor
10/30/2007	CA2278753C Removable protective film for plaster systems, in particular self-adhesive plaster systems, containing active substances
10/30/2007	CA2219991C Taste masking pharmaceutical composition for oral administration
10/30/2007	CA2206995C Use of alkanoyl l-carnitines for the therapeutical treatment of chronic inflammatory bowel diseases
10/30/2007	CA2183577C Methods and compositions for pulmonary delivery of insulin
10/30/2007	CA2171218C Metallospheres and superclusters
10/30/2007	CA2142007C Immunomodulatory peptides
10/26/2007	WO2007127630A1 Controlled released preparations of oxcarbazepine having sigmoidal release profile
10/26/2007	CA2586392A1 A method for alleviating signs and symptoms of spasticity
10/25/2007	WO2007121302A2 Antioxidant compositions for reducing odor in warming lubricant compositions
10/25/2007	WO2007121207A2 Therapeutic belt
10/25/2007	WO2007121077A1 Brimonidine and timolol compositions
10/25/2007	WO2007120930A2 Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives
10/25/2007	WO2007120838A2 Rapidly disintegrating solid oral dosage form of liquid dispersions
10/25/2007	WO2007120768A1 Oral patch with salt of glycyrrhetinic acid water soluble at human mouth temperatures
10/25/2007	WO2007120725A2 Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive
10/25/2007	WO2007120509A2 Virucidal/germicidal mask
10/25/2007	WO2007120500A2 Emulsions and microcapsules with substances having low interfacial tension, methods of making and using thereof
10/25/2007	WO2007120477A2 Products containing a pheromone component
10/25/2007	WO2007120385A2 Low flush niacin formulation
10/25/2007	WO2007120164A1 Biodegradable bb pellet
10/25/2007	WO2007120136A1 Lercanidipine ph dependent pulsatile release compositions
10/25/2007	WO2007120135A1 Lercanidipine immediate release composition
10/25/2007	WO2007120134A1 Lercanidipine modified release compositions
10/25/2007	WO2007119792A1 Dry direct compression fast disintegrating tablet
10/25/2007	WO2007119724A1 Drug delivery particle and method for production thereof
10/25/2007	WO2007119684A1 Spraying agent
10/25/2007	WO2007119656A1 Tamsulosin-containing percutaneous absorption type preparation
10/25/2007	WO2007119601A2 Nanoparticles comprising a pdgf receptor tyrosine kinase inhibitor
10/25/2007	WO2007119486A1 Liquid composition for external application and preparation for external application for treatment of skin ulcer
10/25/2007	WO2007119467A1 Percutaneous absorption promoting agent and percutaneous absorption preparation using the same
10/25/2007	WO2007119185A2 Degradable therapeutic delivery device
10/25/2007	WO2007119028A2 Composition including at least one aqueous phase and at least one fatty phase including ivermectin
10/25/2007	WO2007118884A1 Magnetic nanoparticles compositions and uses thereof
10/25/2007	WO2007118802A1 Aerosol suspension formulations comprising tg 227 ea or tg 134 a as propellants
10/25/2007	WO2007118684A1 Pharmaceutical compositions containing leflunomid

1 ... 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 ... 2991